Masoumeh Khalighi Sikaroudi

Masoumeh Khalighi Sikaroudi

Auto-generated profile, based on publicly available information

Masoumeh Khalighi Sikaroudi

Department of Clinical Nutrition, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
MSMasoumeh Khalighi Sikaroudi
Masoumeh Khalighi Sikaroudi
SSSepideh Soltani
Sepideh Soltani
RKRoya Kolahdouz-Mohammadi
Roya Kolahdouz-Mohammadi
ZCZachary Stephen Clayton
Zachary Stephen Clayton
Maria-Luz FernandezMaria-Luz Fernandez
Maria-Luz Fernandez
FSFarzad Shidfar
Farzad Shidfar

15 December 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
FFFarnaz Farsi
Farnaz Farsi
SZSanaz Rezaei Zonooz
Sanaz Rezaei Zonooz
ZEZohreh Ebrahimi
Zohreh Ebrahimi
HJHanieh Jebraili
Hanieh Jebraili
MMMehrnaz Morvaridi
Mehrnaz Morvaridi
MMMohsen Masoodi
Mohsen Masoodi
Background: Irritable bowel syndrome refers to a subgroup of disorders of gut–brain interaction associated with stress-related symptoms, but gastrointestinal infection can also be considered the leading risk factor. It is well reported that coronavirus disease 2019 can also result in gastroenteritis. Therefore, this study aimed to evaluate the incidence of post-infectious irritable bowel syndrome and stressful status among coronavirus disease 2019 patients. Methods: This cross-sectional study was conducted on adults with coronavirus disease 2019 referred to the Infectious Disease Clinic in Iran from November 2020 to February 2021. Patients who met all eligibility criteria were included in the study. The data were collected using a demographic questionnaire, Rome IV criteria questionnaire, and Hospital Anxiety and Depression Scale. Results: Totally, the data obtained from 233 eligible patients (136 women, 97 men; mean age 38.41) 11.52 (years) were collected and analyzed, and 53.2% of the cases had a moderate coronavirus disease 2019. The analysis showed that 27 (11.6%) patients suffered from irritable bowel syndrome symptoms based on Rome IV criteria after the recovery from the infection. Also, Hospital Anxiety and Depression Scale-based symptoms of depression and anxiety that occurred with coronavirus disease 2019 were reported in 27.4% and 36.9%, respectively. Conclusion: Our finding illustrated that irritable bowel syndrome symptoms based on Rome IV could occur in post-infected coronavirus disease 2019 patients. Also, Hospital Anxiety and Depression Scale-based symptoms of depression and anxiety were more common in females and coronavirus disease 2019 infected patients with clinical symptoms including cough, shortness of breath, and sore throat. Cite this article as: Farsi F, Rezaei Zonooz S, Ebrahimi Z, et al. The incidence of post-infectious irritable bowel syndrome, anxiety, and depression in Iranian patients with coronavirus disease 2019 pandemic: A cross-sectional study. Turk J Gastroenterol. 2022;33(12):1033-1042.

24 January 2021 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
MSMasoumeh Khalighi Sikaroudi
Masoumeh Khalighi Sikaroudi
SSSahar Saraf‐Bank
Sahar Saraf‐Bank
ZCZachary S Clayton
Zachary S Clayton
SSSepideh Soltani
Sepideh Soltani

13 November 2021 in Clinical Nutrition Open Science
Verified
Journal Article
Open access
MSMasoumeh Khalighi Sikaroudi
Masoumeh Khalighi Sikaroudi
SZSanaz Rezaei Zonooz
Sanaz Rezaei Zonooz
ZEZohreh Ebrahimi
Zohreh Ebrahimi
HJHanieh Jebraili
Hanieh Jebraili
FFFarnaz Farsi
Farnaz Farsi
MMMohsen Masoodi
Mohsen Masoodi
Patients with coronavirus disease 2019 (COVID-19) can present anorexia and weight loss due to their symptoms and eating disorder which can lead to immune system weakness and increase the duration of recovery time. We aim to assess the severity and duration of anorexia and weight loss within the infection and recovery period in these patients. We retrospectively identified 233 COVID-19 patients (older than 18 years) were admitted to the Rasoul-e Akram Hospital, from August to December 2020. Their medical records were reviewed by researchers. Then, patients who had inclusion criteria were asked about duration and severity of anorexia, and also weight alternation during the infection and after the recovery period. Analyzed data were collected from 233 COVID-19 patients showed the mean duration of anorexia was 7.08 ± 10.41 days with a significant loss of appetite (- 75.55 ± 88.09, P-value < 0.001) at the period of anorexia compare to appetite improvement. Also, results demonstrated patients, especially males and severe illness subjects, significantly lost weight (P-value <0.001). Conclusion: anorexia and weight loss occur in people infected with the coronavirus and may affect the recovery process of these patients by reducing their food intake. The underlying mechanisms of SARS-CoV-2 related to interaction to the gastrointestinal tract and development of anorexia in these patients need to clarify in future studies.

1 April 2024 in Food Science & Nutrition
Verified
Journal Article
Open access
ZEZohreh Ebrahimi
Zohreh Ebrahimi
ZSZainab Shateri
Zainab Shateri
MNMehran Nouri
Mehran Nouri
MSMasoumeh Khalighi Sikaroudi
Masoumeh Khalighi Sikaroudi
MMMohsen Masoodi
Mohsen Masoodi
MHMahdi Hejazi
Mahdi Hejazi
The components in our food are known as one of the important risk factors for the development of Helicobacter pylori (H. pylori) infection. A balanced diet, rich in fruits and vegetables, and free of fat, sugar, and salt, might protect people from the consequences of H. pylori infection. Therefore, the purpose of this study was to investigate the associations between ultra‐processed foods (UPFs) intake and the risk of H. pylori infection. The case–control study was conducted to assess the intake of UPFs in patients with H. pylori infection compared with healthy individuals. The dietary data of the contributors were collected by a validated food frequency questionnaire (FFQ). To estimate the UPFs intake, the classification of the NOVA food group was utilized. The associations of intake UPFs with H. pylori infection were assessed using binary logistic regression. Finally, dietary data of 150 cases and 302 controls (mean age: 39.5 ± 10.95 years) were analyzed. UPFs intake was associated with higher risk of H. pylori infection (odds ratio (OR) = 1.71; 95% confidence interval (CI): 1.05, 2.79). The association remained constant after adjustment for age, body mass index (BMI), sex, energy intake, physical activity, smoking, and alcohol status (OR = 2.17; 95% CI: 1.22, 3.86). Our data declare that UPFs consumption could have a role in increasing the likelihood of the risk of H. pylori infection. To confirm the current findings, prospective studies are suggested.

26 June 2024 in Heliyon
Verified
Journal Article
Open access
MSMasoumeh Khalighi Sikaroudi
Masoumeh Khalighi Sikaroudi
SSSepideh Soltani
Sepideh Soltani
RKRoya Kolahdouz-Mohammadi
Roya Kolahdouz-Mohammadi
RIRoya Imanifard
Roya Imanifard
SAShima Abdollahi
Shima Abdollahi
GFGholamreza Mohammadi Farsani
Gholamreza Mohammadi Farsani
Dietary components can influence the incidence of colorectal cancer (CRC). Folate is one of the compounds that plays an essential role in the formation of DNA structures, which can lead to or prevent tumorigenesis. The present study is the first systematic review and dose–response meta-analysis of cohort studies evaluating the association between dietary folate intake and the risk of CRC. The PubMed/Medline, Scopus, and ISI Web of Science databases were systematically searched for cohort studies that assessed the association between folate intake and CRC up to January 2024. Summary relative risks (RRs) and 95 % confidence intervals (CIs) were calculated using a random effects model. Also, linear and nonlinear dose-response analyses were conducted for the dose-response associations between folate intake and risk of CRC. Eighteen prospective cohort studies with 931,469 participants, 14,860 CRC patients, 3536 colon cancer (CC) patients, and 1075 rectal cancer (RC) patients were included in the analysis. The summary RR of CRC for each 100-μg increase in dietary folate intake was 0.97 (95 % CI: 0.95–0.99, I2: 0.0 %, P-heterogeneity: 0.616), which can be related to BMI (0.97 (95 % CI: 0.95–0.99)); a more protective effect was also observed in subjects who drank alcohol (0.97 (95 % CI: 0.95–0.99)) and those who smoked (0.97 (95 % CI: 0.95–0.99)). Additionally, it was positively related to a 7 % lower risk of CC (0.93 (95 % CI: 0.87–0.99, I2: 33.7 %, P-heterogeneity: 0.159)), and the null relation for RC was 0.98 (95 % CI: 0.90–1.08), I2: 16.6 %, P-heterogeneity: 0.309). There was evidence of nonlinearity in which up to 500 μg/day dietary folate intake was inversely associated with CC (P nonlinearity = 0.04). The findings showed an inverse association between dietary folate intake and the risk of CRC, especially in high-risk persons, those who have a higher BMI, alcohol drinkers, and smokers.